Bob Wolfenson, Photographer and Artist:
“When we look at movement through a lens, it is redefined, and what we thought was ordinary becomes Extra[Ordinary]. Our bodies are made for movement – the flex of a muscle, the bend in a joint…, every element works together without us thinking, yet it is Extra[Ordinary].”
Erasmo Schutzer, President, Lonza Consumer Health & Nutrition:
“Movement is key to a healthy lifestyle – whatever your age. Consumer education is central to our strategy, as we look to build the UC-II® brand and help our customers to grow their joint health business with innovative product lines.”
Morristown, NJ (USA), 24 September 2019 – Lonza Consumer Health & Nutrition announces the launch of a comprehensive new initiative designed to help educate consumers on the importance of joint health earlier in life. The high-impact Lifestyle in Motion™ campaign kicked off yesterday with a photography exhibition held in Chelsea, New York (USA). Titled Move to the Extra[Ordinary]™, the work explores movement in everyday life and its impact on health, wellbeing and aspirations.
Move to the Extra[ordinary]™: A Photography Exhibit by Lonza
Curated and shot by the acclaimed Brazilian fashion and portrait photographer Bob Wolfenson, the Move to the Extra[Ordinary]™ exhibit asks consumers to look again at ordinary movement – from the small, daily movements that we take for granted, to the act of pushing our bodies to their physical limit.
Told in a series of photographic essays, the campaign emphasizes actual movements in sequence, and explores their importance and impact on our lifestyle aspirations.
Bob Wolfenson explains: “When we look at movement through a lens, it is redefined, and what we thought was ordinary becomes Extra[Ordinary]. Our bodies are made for movement – the flex of a muscle, the bend in a joint…, every element works together without us thinking, yet it is Extra[Ordinary].”
Supporting Joint Health for a Lifestyle in Motion™
“Movement is key to a healthy lifestyle – whatever your age. Consumer education is central to our strategy, as we look to build the UC-II® brand and help our customers to grow their joint health business with innovative product lines,” comments Erasmo Schutzer, President, Lonza Consumer Health & Nutrition.
Lonza’s UC-II® undenatured type II collagen is a market-leading ingredient that is clinically studied to support joint comfort, flexibility and mobility, helping consumers remain active and maintain joint health. It is proposed to work in the gut by triggering the immune system to target the body’s natural process of rebuilding and repairing cartilage. A randomized, double-blind, placebo-controlled study found that a small, daily dose of 40 mg of UC-II® undenatured type II collagen could support joint health and flexibility in healthy subjects, regardless of their age group.
 Lugo JP, Saiyed ZM, Lau FC, et al. J Int Soc Sports Nutr. 2013;10:48.
Join the Movement
As a leader in joint health, Lonza will be presenting its innovative formulation concepts featuring UC-II® undenatured type II collagen at booth 4339 at SupplySide West. More information on the Lifestyle in Motion™ campaign, and UC-II® undenatured type II collagen can be found at www.lifestyle-inmotion.com, or www.lonza.com.
Lonza is an integrated solutions provider that creates value along the Healthcare Continuum®. Through our Pharma Biotech & Nutrition segment and our Specialty Ingredients segment businesses, we harness science and technology to serve markets along this continuum. We focus on creating a healthy environment, promoting a healthier lifestyle and preventing illness through consumers' preventive healthcare, as well as improving patient healthcare by supporting our customers to deliver innovative medicines that help treat or even cure severe diseases.
Patients and consumers benefit from our ability to transfer our pharma know-how to the healthcare, hygiene and fast-moving consumer goods environment and to the preservation and protection of the world where we live.
Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 100 sites and offices and approximately 15,500 full-time employees worldwide at the end of 2018. The company generated sales of CHF 5.5 billion in 2018 with a CORE EBITDA of CHF 1.5 billion. Further information can be found at www.lonza.com.
Lonza Contact Details
Aparna Parikh Head of Global Marketing Communications
Lonza Consumer Health & Nutrition
Additional Information and Disclaimer
Lonza Group Ltd has its headquarters in Basel, Switzerland, and is listed on the SIX Swiss Exchange. It has a secondary listing on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza Group Ltd is not subject to the SGX-ST’s continuing listing requirements but remains subject to Rules 217 and 751 of the SGX-ST Listing Manual.
Certain matters discussed in this news release may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this news release due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this news release.